These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 15700970)

  • 1. Regio- and enantioselective intermolecular rhodium-catalyzed [2+2+2] carbocyclization reactions of 1,6-enynes with methyl arylpropiolates.
    Evans PA; Lai KW; Sawyer JR
    J Am Chem Soc; 2005 Sep; 127(36):12466-7. PubMed ID: 16144375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gold(i)-catalyzed addition of aldehydes to cyclopropylidene bearing 6-aryl-1,5-enynes.
    Roselli CA; Gagné MR
    Org Biomol Chem; 2016 Nov; 14(47):11261-11265. PubMed ID: 27853802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallacycle-Mediated Cross-Coupling in Natural Product Synthesis.
    O'Rourke NF; Kier MJ; Micalizio GC
    Tetrahedron; 2016 Nov; 72(45):7093-7123. PubMed ID: 27765997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The origin of the ligand-controlled regioselectivity in Rh-catalyzed [(2 + 2) + 2] carbocyclizations: steric
    Crandell DW; Mazumder S; Evans PA; Baik MH
    Chem Sci; 2015 Dec; 6(12):6896-6900. PubMed ID: 28757978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational Insight Concerning Catalytic Decision Points of the Transition Metal Catalyzed [2 + 2 + 1]
    Bayden AS; Brummond KM; Jordan KD
    Organometallics; 2006 Oct; 25(22):5204-5206. PubMed ID: 26005240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivity and chemoselectivity of allenes in Rh(I)-catalyzed intermolecular (5 + 2) cycloadditions with vinylcyclopropanes: allene-mediated rhodacycle formation can poison Rh(I)-catalyzed cycloadditions.
    Hong X; Stevens MC; Liu P; Wender PA; Houk KN
    J Am Chem Soc; 2014 Dec; 136(49):17273-83. PubMed ID: 25379606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic synthesis of oligoene and enyne derivatives through carbometalation of internal alkynes.
    Satoh T; Tsurugi H; Miura M
    Chem Rec; 2008; 8(5):326-36. PubMed ID: 18958852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diastereoselective intramolecular temporary silicon-tethered rhodium-catalyzed [4+2+2] cycloisomerization reactions: regiospecific incorporation of substituted 1,3-butadienes.
    Evans PA; Baum EW
    J Am Chem Soc; 2004 Sep; 126(36):11150-1. PubMed ID: 15355086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhodium-catalyzed cycloisomerization of 1,6-enynes with an intramolecular halogen shift: reaction scope and mechanism.
    Tong X; Li D; Zhang Z; Zhang X
    J Am Chem Soc; 2004 Jun; 126(24):7601-7. PubMed ID: 15198608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rh(II)-Catalyzed skeletal reorganization of 1,6- and 1,7-enynes through electrophilic activation of alkynes.
    Ota K; Lee SI; Tang JM; Takachi M; Nakai H; Morimoto T; Sakurai H; Kataoka K; Chatani N
    J Am Chem Soc; 2009 Oct; 131(42):15203-11. PubMed ID: 19807073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diastereoselective metal-catalyzed [4 + 2 + 2] carbocyclization reactions utilizing a rhodium N-heterocyclic carbene (NHC) complex: the first example of a rhodium NHC-catalyzed [m + n + o] carbocyclization.
    Evans PA; Baum EW; Fazal AN; Pink M
    Chem Commun (Camb); 2005 Jan; (1):63-5. PubMed ID: 15614373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic insights on the cycloisomerization of polyunsaturated precursors catalyzed by platinum and gold complexes.
    Soriano E; Marco-Contelles J
    Acc Chem Res; 2009 Aug; 42(8):1026-36. PubMed ID: 19480448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diastereoselective intermolecular rhodium-catalyzed [4 + 2 + 2] carbocyclization reactions: computational and experimental evidence for the intermediacy of an alternative metallacycle intermediate.
    Baik MH; Baum EW; Burland MC; Evans PA
    J Am Chem Soc; 2005 Feb; 127(6):1602-3. PubMed ID: 15700970
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.